Chemotherapy Flashcards
Paclitaxel
Plant Alkaloid
Breast, pancreatic, lung, H/N
Peripheral neuropathy, milky appearance, skin rash
Dactinomycin
Antitumor Antibiotic
Brentuximab Vedotin
Monoclonal Antibody-targets CD30
Hodgkin Lymphoma; NHL
Infusion related reactions, peripheral neuropathy, myelosuppression
Doxorubicin
Antitumor Antibiotic
Breast; Lymphoma; sarcoma; liver;
cardiomyopathy, vesicant, anthracycline, max cumulative dose of 550mg/m2 (with Cytoxan may be reduced to 450mg/m2)
Testing prior: ECHO/MUGA
Ado-Trastuzumab emtansine
Monoclonal Antibody- targets Her 2
Breast
Infusion related reactions, hepatic toxicity (elevated LFT’s), pulmonary toxicity, altered LVEF, thrombocytopenia, bleeding
Testing: ECHO/Muga
Everolimus
mTOR inhibitor
Renal; breast; liver
Mucositis, cyp3A interactions
Aldesleukin (IL-2)
Biologic Therapy
Melanoma; renal
Capillary leak
Alemtuzumab
Monoclonal Antibody-targets CD52
Lymphoma or CLL
Severe lymphodepletion need prophylactic antibiotics.
HSR
Pemetrexed
Antimetabolite
lung
Folic acid, Vit B12 replacement
Dex for fluid retention.
Melphalan
Alkylating Agent
CLL, MM
High dose- severe mucositis (oral cryotherapy)
Amifostine
Not Chemo- chemoprotectant
Hypotension, N/V, Not Chemo
cytarabine
Antimetabolite
Leukemia
High dose (greater than 1gm/m2)-cerebellar toxicity and ocular (keratitis), myelosuppression
Testing: Cerebellar assessment
Darbopoietin alfa
Growth Factor
Avoid in curable cancers- risk of progression and hyper viscosity (stroke)
Pamidronate
Bisphosphonate
Renal toxicity
Used for hypercalcemia and to prevent bone loss, osteonecrosis of the jaw
Testing: Check kidney function prior and make sure do dental work prior
Nelarabine
Nucleoside metabolite inhibitor
Ofatumumab
Blocks CD20 MAB
Lymphoma
Infusion reaction; Hepatitis reactivation
Testing: Hepatitis panel
Arsenic Trioxide
Prolonged QTc, correct K and Mag
Testing: EKG
Asparginase
Asparagine specific activity ALL Allergic reaction Coagulopathies Pancreatitis
All Trans Retinoic Acid (ATRA)
Retinoic acid receptor
AML
Pulmonary syndrome that requires dex
Atezolizumab
PDL-1 inhibitor
Urothelial cancer; lung
Immune mediated reactions
Bevacizumab
Antiangiogenesis
Colon; ovary; brain; lung
High Bp, headaches, nose bleeds.
Poor wound healing, GI perforation- wait 4 weeks for surgery
Avelumab
Monoclonal antibody- Targets PDL-1
urothelial
Infusion related reactions, Immune mediated reactions
Azaciditine
Hypomethylating Agent
MDS; AML
In SQ form- skin reaction (2 shots), IV short stability, don’t hold dose for low bld ct
Carmustine
Nitrosourea
Brain; NHL; MM
Delayed pulmonary toxicity
Mixed in alcohol